ARTICLE
|
doi:10.20944/preprints202309.0131.v1
Subject:
Medicine And Pharmacology,
Cardiac And Cardiovascular Systems
Keywords:
BNT162b2 vaccine; Pfizer/BioNTech; cardiovascular events; COVID-19
Online: 4 September 2023 (08:19:54 CEST)
REVIEW
|
doi:10.20944/preprints202402.0421.v1
Subject:
Medicine And Pharmacology,
Immunology And Allergy
Keywords:
Pfizer-BioNTech; Modern; Novavax; AstraZeneca; Sinopharm; Janssen; vaccine effectiveness (VE); COVID-19; Trinidad and Tobago
Online: 7 February 2024 (08:12:24 CET)
ARTICLE
|
doi:10.20944/preprints202310.0379.v1
Subject:
Biology And Life Sciences,
Immunology And Microbiology
Keywords:
Pfizer-BioNTech vaccine; SSA, S-IgG antibody dynamics; S-IgM; S-IgA; SARS-CoV-2; breakthrough Infections
Online: 9 October 2023 (04:35:48 CEST)
ARTICLE
|
doi:10.20944/preprints202402.0541.v1
Subject:
Biology And Life Sciences,
Immunology And Microbiology
Keywords:
SARS-CoV-2; SARS-CoV-2 neutralizing antibodies; COVID-19; Pediatric Population; BNT162b2 (Pfizer-BioNTech); CoronaVac (Sinovac); Heterologous vaccination; Chile
Online: 9 February 2024 (09:16:59 CET)
ARTICLE
|
doi:10.20944/preprints202308.1465.v1
Subject:
Public Health And Healthcare,
Public Health And Health Services
Keywords:
Adolescent; children; 12-17 years COVID-19 vaccine; fully vaccinated; partially vaccinated; vaccination status; RT-PCR-positive; Pfizer; BNT162b2; vaccine effectiveness
Online: 22 August 2023 (03:02:19 CEST)